43 web-programmer-developer-"https:" "https:" "https:" "https:" "https:" "https:" "https:" "UCL" "UCL" research jobs at University of Utah
Sort by
Refine Your Search
-
discovery and intervention development aimed at improving health outcomes and care delivery across clinical, community, and policy environments. Each trainee will participate in a two-year program (year two
-
. The University does not discriminate on the basis of sex in the education program or activity that it operates, as required by Title IX and 34 CFR part 106. The requirement not to discriminate in education
-
of the clinical research program or laboratory. Tasks will vary by department and research category. Typically, manage the front desk, organize files, and perform other clerical duties associated with
-
trial on ketamine-assisted therapy + a mindfulness training program for patients with opioid use disorder as well as possibly other psychedelic trials. This would involve working with a clinical research
-
Institute’s mission and this position. Responsibilities The University/Huntsman Cancer Institute (https://healthcare.utah.edu/huntsmancancerinstitute/) is a vibrant community, home to exceptional epidemiologic
-
-university program in 2021. The Center works especially closely with 10 transdisciplinary Center Program Directors who hold faculty appointments in 4 U of U departments and will work closely with faculty and
-
conditions, genetic information, or protected veteran’s status. The University does not discriminate on the basis of sex in the education program or activity that it operates, as required by Title IX and 34
-
the Division of Transplant Surgery. This role plays a central part in the collection and processing of surgical specimens, development and maintenance of a transplant biorepository, and accurate abstraction and
-
-$26.94 Close Date 01/29/2026 Priority Review Date (Note - Posting may close at any time) Job Summary The Division of Epidemiology’s Program for Addiction Research, Clinical Care, Knowledge, and Advocacy
-
lead to tissue failure and cancer, and to develop novel therapeutic approaches to mitigate and treat deleterious phenotypes that arise in patients with impaired DNA and RNA maintenance pathways. Some